Weekly CagriSema Injection Combination Yields Significant Weight Loss in Phase IIIb Trial
A clinical trial published in The Lancet Diabetes & Endocrinology reports that two lower doses of the investigational injection CagriSema led to substantial weight reduction in adults with obesity or overweight.
🥗NutritionPhoto: Medical Xpress
Key points
- REDEFINE 9 trial evaluated CagriSema in 309 adults over 68 weeks.
- Average weight loss reached over 20% for active treatment groups.
- CagriSema remains an investigational treatment requiring further trials.
A recent Phase IIIb clinical trial published in The Lancet Diabetes & Endocrinology has demonstrated that weekly injections of CagriSema—a combination of two appetite-suppressing agents, cagrilintide and semaglutide—may significantly reduce body weight in adults living with obesity or overweight who also have a weight-related medical condition such as high blood pressure or sleep apnea. The 68-week study, known as REDEFINE 9, examined 309 participants across international sites in the U.S., U.K., Canada, France, and Germany, combining the medication regimen with lifestyle counseling on diet and physical exercise.
According to the findings, participants who maintained treatment achieved an average weight loss of 20.7% at a 1.7 mg dosage and 21.0% at a 1.0 mg dosage, contrasted with a 2.0% reduction seen in the placebo group. Furthermore, roughly half of those receiving the active treatment lost at least 20% of their baseline body weight, alongside notable decreases in waist circumference. The study authors indicate that these results point toward potential dosing flexibility for personalized care strategies, though they note that CagriSema remains investigational and requires additional study in larger and more diverse populations.
What to know: While these findings highlight potential advancements in weight management pharmacotherapy, the research represents an early-stage exploration involving a specific demographic. Readers are advised to consult a qualified healthcare professional before making any personal medical or lifestyle decisions.
Source Medical Xpress — medicalxpress.com/news/2026-11-weekly-weight-loss-combo.html ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…